The sterile medical packaging market is estimated to grow at a CAGR of 6.78% to reach a market size of US$46.247 billion in 2027 from US$29.210 billion in 2020.
Increasing concerns of the market players are making them adopt and use advanced packaging solutions to avoid contamination and keep the consumers and end-users free from harm. Proper and effective packaging is an essential step and process in the medical and healthcare industry to minimize the chances of contamination of instruments and medical equipment that are about to be packed so that diseases are not spread. In addition, many of the market players, to prevent the entry of bacteria during the sterilization process, which takes place before the packaging is done, are using safer practices such as installing HVAC systems equipped with technical and advanced grade HEPA filters to keep the contaminants such as bacteria and viruses out of their facilities. Thus, this is leading to a surge in demand for sterilization medical packaging products and is fueling the market growth over the forecast period.
The increasing participation of agents and organizations in setting guidelines to tackle the problem of contamination during the packaging process and the strict rules that must be complied with during the packaging of medical materials.
There is a presence of stringent guidelines by different organizations. For example, The Association of Surgical Technologies (AST) put forward some SOPs (Standards of Practice) that were researched and authored by the AST Education and Professional Standards Committee and were approved by the AST Board of Directors. These standards were developed to provide support to healthcare facilities in the reinforcement of the most effective and best practices regarding the material to be used for sterilized packaging of items. These criteria were provided to make the healthcare facilities aware that they were responsible for promoting the development, approvals, and policy formation to evaluate sterilization packaging materials. The Standard of Practice I was the proper evaluation before the adoption and purchase, which included the proper testing of the packaging materials so that they can meet the performance standards, which were the sterilization should be able to not deteriorate till the end of the product use. The package can easily be opened via aseptic methods without contamination. The contents must be covered properly and thoroughly. The package must be resistant to punctures and other problems. The packaging materials must not contain and be made of toxic materials, among other standards.
Other standards of practice involve reusable packaging materials that should be laundered, inspected, and properly stored to preserve the packaging properties. Paper-plastic peel pouches or peel packs must be used only for the sterilization and packaging of small items. In the case of the wrapped packages, they must be prepared to facilitate the ease of opening the package and transferring it to the sterile field, wherein the sterile conditions must be maintained, among other standards of practice. In addition, the Food and Drug Administration (FDA) classifies the products and materials that are used for packaging medical materials using sterile methods according to Class II performance standards. In conjunction, it provides some steps and regulations under the Sterilization Process Controls, which include some of the inspectional objectives, which must be carried out to ensure, the methods being used are proper and properly validated. The importance and purpose of this process control subsystem are to manufacture products that meet the regulations and specifications. For the sterilization processes, the primary device specification used is increasingly desirable and suitable and called the Sterility Assurance Level (SAL). Other specifications include sterilant residue levels and the levels of endotoxins. Therefore, the demand for sterile medical packaging solutions to avoid penalties is leading to a boost in market growth.
Product Offerings by Major Market Players
The better, advanced, and diverse varieties of sterilization medical packaging products with enhanced properties can effectively prevent contamination and the spread of diseases to the end-users. These products are being offered by existing and new players in different markets. They are estimated to lead to increased adoption and propel market growth further over the forecast period.
Some of the examples of the product offerings are as follows:
The North American region to hold a considerable share over the forecast period and the Asia Pacific to increase its share
The increasing investments in the R&D of better sterilization medical packing solutions and products to cater to the increasing demand from the end-user industries coupled with the well-established medical facilities and healthcare industry and the flourishing packaging industry in the countries such as the U.S.
In addition, the Asia Pacific region is expected to hold a considerable share and increase its share over the forecast period, which is attributable to the fact that there are increasing efforts being made in the form of product launches and investments to improve the standing of the packaging and medical industry.
The COVID-19 pandemic has caused the healthcare sector to expand quickly. People have become more concerned about health and safety because of the pandemic, which has prompted the healthcare sector to strictly adhere to new government laws and regulations concerning hygiene. Additionally, the rapidly expanding patient population has overloaded hospital systems, placing a significant strain on the healthcare sector. Owing to the need to stop viral infection and dissemination, there is a rise in the need for sterile packaging technology. Diagnostic procedures, personal protective equipment (PPE), medical ventilators, as well as other essential medical supplies are suddenly in demand as a result of the epidemic. As a result, there is a greater demand for sterile/aseptic packaging, anti-viral packaging, and novel ecological packaging choices. However, there is a shortage of healthcare supplies due to excessive demand. For instance, the Annals of Intern Medicine estimates that by the end of March 2020, there were only 12 million N95 respirators as well as 1,60,000 ventilators in use in the United States. The market is anticipated to stabilize over the next couple of years as governments in these nations take steps to standardize the functioning of their sectors.
|Market Size Value in 2020||US$29.210 billion|
|Market Size Value in 2027||US$46.247 billion|
|Growth Rate||CAGR of 6.78% from 2020 to 2027|
|Forecast Unit (Value)||USD Billion|
|Segments Covered||Product Type, Material Type, Sterilization Method, Application, And Geography|
|Regions Covered||North America, South America, Europe, Middle East and Africa, Asia Pacific|
|Companies Covered||DuPont, Amcor plc, Berry Global Inc., ProAmpac, Wipak Group, WestRock Company, Teckni-Plex, Placon, Mitsubishi Chemical Corporation, Eagle Flexible Packaging, UFP Technologies, Sonoco Products Company, Steripack Ltd, Orchid MPS Holdings, LLC|
|Customization Scope||Free report customization with purchase|
Frequently Asked Questions (FAQs)
Q1. What is the size of the sterile medical packaging market?
A1. Sterile Medical Packaging Market was valued at US$29.210 billion in the year 2020.
Q2. What will be the sterile medical packaging market size by 2027?
A2. The sterile medical packaging market is estimated to reach a market size of US$46.247 billion by 2027.
Q3. What are the growth prospects for the sterile medical packaging market?
A3. The global sterile medical packaging market is estimated to grow at a CAGR of 6.78% over the forecast period.
Q4. How is the sterile medical packaging market segmented?
A4. The sterile medical packaging market has been segmented by product type, material type, sterilization method, application, and geography.
Q5. Which region holds the largest market share in the sterile medical packaging market?
A5. The North American region holds a considerable share of the sterile medical packaging market over the forecast period.
1.1. Market Overview
1.2. COVID-19 Scenario
1.3. Market Definition
1.4. Market Segmentation
2. Research Methodology
2.1. Research Data
3. Executive Summary
3.1. Research Highlights
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. Sterile Medical Packaging Market Analysis, by Product Type
5.5. Blisters and Ampoules
6. Sterile Medical Packaging Market Analysis, by Material Type
6.2.1. Polyvinyl chloride (PVC)
6.2.2. Polypropylene (PP)
6.2.3. Polyethylene (PE)
6.3.2. Soda-Lime-Silica Glass
6.5. Paper And Paperboard
7. Sterile Medical Packaging Market Analysis, by Sterilization Method
7.2.1. Ethylene Oxide
7.2.2. Hydrogen Peroxide
7.3.1. Ionization radiation
7.3.2. Non-Ionization radiation
7.4. High Temperature/Pressure
7.4.2. Plasma gas Sterilizers
7.4.3. Vaporized Hydrogen Peroxide Sterilizers
8. Sterile Medical Packaging Market Analysis, by Application
8.2. Surgical Instruments
8.3. Pharmaceutical and Biological
9. Sterile Medical Packaging Market Analysis, by Geography
9.2. North America
9.2.1. United States
9.3. South America
9.5. Middle East and Africa
9.5.1. Saudi Arabia
9.5.2. United Arab Emirates
9.6. Asia Pacific
9.6.4. South Korea
10. Competitive Environment and Analysis
10.1. Major Players and Strategy Analysis
10.2. Emerging Players and Market Lucrativeness
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Vendor Competitiveness Matrix
11. Company Profiles
11.2. Amcor plc
11.3. Berry Global Inc.
11.5. Wipak Group
11.6. WestRock Company
Mitsubishi Chemical Corporation
Eagle Flexible Packaging
Sonoco Products Company
Orchid MPS Holdings, LLC
All our studies come with 2 months of analyst support.
We are in compliance with the global privacy laws.